N. Leigh Anderson, Ph.D. is a Founder and CEO of SISCAPA Assay Technologies, (www.SISCAPA.com), and also heads the Plasma Proteome Institute. SISCAPA aims to improve clinical diagnostics with sensitive, specific peptide-level assays for protein biomarkers. Dr. Anderson was previously Chief Scientific Officer at Large Scale Biology Corporation, which he co-founded in 1985, and has served on the boards of directors of three public technology companies including Dade Behring, a global diagnostics company acquired by Siemens. Dr. Anderson obtained a B.A. in Physics from Yale and a Ph.D. in Molecular Biology from Cambridge University (England), has published 160 papers, been granted 40 US Patents, and was awarded the 2009 HUPO Distinguished Achievement Award in Proteomic Science.